A COVID-19 study in Britain looked at the medical records of 1.7 million children but did not conclude the same number of ...

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national ...

GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will ...

A young man who allegedly died a “horrific” death after consuming allegedly contaminated antibiotics he bought at a ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

U.S. Sen. Ron Johnson has threatened to issue a subpoena when he becomes chairman of the Permanent Subcommittee on ...

Anthropic announced it received an additional $4 billion investment from Amazon as they deepened their partnership with AWS ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...